TPP Healthcare, a strategic advisory firm specializing in cross-border transactions between Western and Chinese healthcare companies, announces its launch of www.tpphealthcare.com – a direct market access strategy site. On the site, current and prospective clients will find useful information about the global healthcare industry, TPP’s services and recent company production numbers. Additionally, viewers will gain valuable insight […]
Category: Innovation
Industry Headlines I Care About…
News Round Up! My Communications Team recently flagged some articles I thought I’d share. Outside of the CFDA publishing a draft Decision for Adjusting the Administrative Regime for Import Drug Registrations, there is a lot of movement in the cross-border healthcare front… The Wall Street Journal: China Emerges as Powerhouse for Biotech Drugs Drugs are classified into two major categories based […]
My Time at CPEA
Today I had the honor of speaking at the annual Chinese Pharmaceutical Enterprises Association (CPEA) Meeting. Key talking points were: Why is China relevant to my NA/EU clients: The importance of the Chinese healthcare market and Chinese capital to the outside world. Why Chinese should invest in these overseas markets: I stressed the real opportunity […]
In the News…
News Round Up! FierceBiotech: Donald Trump’s First 100 Days, and beyond, for BiopharmaThe article looks at what the next four years could mean for the biopharma industry through Trump’s picks for healthcare top jobs and the power his policies will have over regulatory terms and drug pricing. BioSpectrum Asia: China Will Continue to Rise as a Key Base […]
2017 Starts Strong: Success in San Francisco
For those of you who joined us last month, a warm thank you is owed. Our TPP Healthcare China Partnering Forum during JPM Healthcare Week was a homerun. The numbers: 300 attendees throughout the week, 500 live-stream registrants in China, 80 panelists, 60+ gallons of coffee, endless one-on-one meetings in our private ballrooms and 8K+ impressions […]